» Articles » PMID: 1381914

Bank Vole Monoclonal Antibodies Against Puumala Virus Envelope Glycoproteins: Identification of Epitopes Involved in Neutralization

Overview
Journal Arch Virol
Specialty Microbiology
Date 1992 Jan 1
PMID 1381914
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Bank vole (Clethrionomys glareolus) monoclonal antibodies (MAbs) against the two envelope glycoproteins (G 1 and G 2) of the Puumala (PUU) virus were generated and characterized. Analyses of the MAbs' antigen and epitope specificities showed non-overlapping reactivities of one anti-G 1 and two anti-G 2 MAbs. A significant neutralizing activity was shown by the anti-G 1 and one of the anti-G 2 MAbs, suggesting the existence of at least one neutralizing domain on each of the two glycoproteins. The two neutralizing MAbs reacted with eight PUU-related (serotype 3) virus strains, but did not react with Hantaan, Seoul, or Prospect Hill viruses in an immunofluorescence assay, indicating reactivity with epitopes unique for PUU virus. The non-neutralizing anti-G 2 MAb also reacted with Seoul virus, revealing the presence of a conserved G 2-epitope common for PUU and Seoul viruses, not involved in neutralization. Competitive binding of the MAbs and sera from nephropathia epidemica patients indicated that the defined neutralizing and non-neutralizing epitopes of the glycoproteins were immunodominant also in humans. In another experiment, magnetic beads coated with two MAbs were bound with the virus glycoproteins and used for selective enrichment of cells secreting anti-glycoprotein antibodies.

Citing Articles

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.

Engdahl T, Binshtein E, Brocato R, Kuzmina N, Principe L, Kwilas S Elife. 2023; 12.

PMID: 36971354 PMC: 10115451. DOI: 10.7554/eLife.81743.


Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention.

Sehgal A, Mehta S, Sahay K, Martynova E, Rizvanov A, Baranwal M Viruses. 2023; 15(2).

PMID: 36851775 PMC: 9966805. DOI: 10.3390/v15020561.


Neutralizing Antibody Titers in Hospitalized Patients with Acute Puumala Orthohantavirus Infection Do Not Associate with Disease Severity.

Iheozor-Ejiofor R, Vapalahti K, Sironen T, Levanov L, Hepojoki J, Lundkvist A Viruses. 2022; 14(5).

PMID: 35632643 PMC: 9143849. DOI: 10.3390/v14050901.


The Immune Correlates of Vaccine.

Bae J, Kim J, Park M, Lee G, Park H, Song K Vaccines (Basel). 2021; 9(5).

PMID: 34069997 PMC: 8157935. DOI: 10.3390/vaccines9050518.


Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein.

Rissanen I, Stass R, Krumm S, Seow J, Hulswit R, Paesen G Elife. 2020; 9.

PMID: 33349334 PMC: 7755396. DOI: 10.7554/eLife.58242.


References
1.
BRUMMER-KORVENKONTIO M, Vaheri A, Hovi T, von Bonsdorff C, Vuorimies J, Manni T . Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis. 1980; 141(2):131-4. DOI: 10.1093/infdis/141.2.131. View

2.
Yamanishi K, Dantas Jr J, Takahashi M, Yamanouchi T, Domae K, Takahashi Y . Antigenic differences between two viruses, isolated in Japan and Korea, that cause hemorrhagic fever with renal syndrome. J Virol. 1984; 52(1):231-7. PMC: 254510. DOI: 10.1128/JVI.52.1.231-237.1984. View

3.
Niklasson B, Le Duc J . Isolation of the nephropathia epidemica agent in Sweden. Lancet. 1984; 1(8384):1012-3. DOI: 10.1016/s0140-6736(84)92344-4. View

4.
BRUMMER-KORVENKONTIO M, Henttonen H, Vaheri A . Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica. Scand J Infect Dis Suppl. 1982; 36:88-91. View

5.
Dantas Jr J, Okuno Y, Asada H, Tamura M, Takahashi M, Tanishita O . Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology. 1986; 151(2):379-84. DOI: 10.1016/0042-6822(86)90058-9. View